Verana Health is a company based in the United States that operates within the software industry, specifically focusing on healthcare software solutions. Founded in 2018, the company employs between 201 and 500 individuals and generates revenue of approximately $43 million. Verana Health's expertise lies in utilizing data from clinical registries to enhance research and improve patient outcomes. A notable aspect of their work involves the integration of data from the Axon and IRIS registries, which is highlighted in a recent presentation discussing the comparison of visual outcomes between patients with neuromyelitis optica (NMO) and multiple sclerosis (MS). The presentation emphasizes the significance of vision as a critical outcome measure in MS and NMO, indicating that visual system function is closely related to quality of life in these patients. Verana Health’s contributions to the field are underscored by their involvement in research and their engagement with various medical and academic institutions, reflecting their commitment to advancing healthcare through data-driven insights.